SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS

The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is -C(H) or -N ; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally subst...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HELLMAN SARAH LYNNE, HOLLINSHEAD SEAN PATRICK, COHEN MICHAEL PHILIP, TIDWELL MICHAEL WADE, FILLA SANDRA ANN
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HELLMAN SARAH LYNNE
HOLLINSHEAD SEAN PATRICK
COHEN MICHAEL PHILIP
TIDWELL MICHAEL WADE
FILLA SANDRA ANN
description The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is -C(H) or -N ; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2188268TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2188268TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2188268TT13</originalsourceid><addsrcrecordid>eNrjZPANDnUKDvEMCQ1xdVEI8AxwDXKM8vSL9FEIiASzXIMVHP1cQDxPFwgvWMFU1yPEXCHI1dk1IMQ_CCgf4uju7-cZHBLMw8CalphTnMoLpbkZFN1cQ5w9dFML8uNTiwsSk1PzUkvigz2NDC0sjMwsQkIMjYlRAwA-US8-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>HELLMAN SARAH LYNNE ; HOLLINSHEAD SEAN PATRICK ; COHEN MICHAEL PHILIP ; TIDWELL MICHAEL WADE ; FILLA SANDRA ANN</creator><creatorcontrib>HELLMAN SARAH LYNNE ; HOLLINSHEAD SEAN PATRICK ; COHEN MICHAEL PHILIP ; TIDWELL MICHAEL WADE ; FILLA SANDRA ANN</creatorcontrib><description>The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is -C(H) or -N ; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111130&amp;DB=EPODOC&amp;CC=SI&amp;NR=2188268T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111130&amp;DB=EPODOC&amp;CC=SI&amp;NR=2188268T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HELLMAN SARAH LYNNE</creatorcontrib><creatorcontrib>HOLLINSHEAD SEAN PATRICK</creatorcontrib><creatorcontrib>COHEN MICHAEL PHILIP</creatorcontrib><creatorcontrib>TIDWELL MICHAEL WADE</creatorcontrib><creatorcontrib>FILLA SANDRA ANN</creatorcontrib><title>SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS</title><description>The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is -C(H) or -N ; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPANDnUKDvEMCQ1xdVEI8AxwDXKM8vSL9FEIiASzXIMVHP1cQDxPFwgvWMFU1yPEXCHI1dk1IMQ_CCgf4uju7-cZHBLMw8CalphTnMoLpbkZFN1cQ5w9dFML8uNTiwsSk1PzUkvigz2NDC0sjMwsQkIMjYlRAwA-US8-</recordid><startdate>20111130</startdate><enddate>20111130</enddate><creator>HELLMAN SARAH LYNNE</creator><creator>HOLLINSHEAD SEAN PATRICK</creator><creator>COHEN MICHAEL PHILIP</creator><creator>TIDWELL MICHAEL WADE</creator><creator>FILLA SANDRA ANN</creator><scope>EVB</scope></search><sort><creationdate>20111130</creationdate><title>SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS</title><author>HELLMAN SARAH LYNNE ; HOLLINSHEAD SEAN PATRICK ; COHEN MICHAEL PHILIP ; TIDWELL MICHAEL WADE ; FILLA SANDRA ANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2188268TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HELLMAN SARAH LYNNE</creatorcontrib><creatorcontrib>HOLLINSHEAD SEAN PATRICK</creatorcontrib><creatorcontrib>COHEN MICHAEL PHILIP</creatorcontrib><creatorcontrib>TIDWELL MICHAEL WADE</creatorcontrib><creatorcontrib>FILLA SANDRA ANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HELLMAN SARAH LYNNE</au><au>HOLLINSHEAD SEAN PATRICK</au><au>COHEN MICHAEL PHILIP</au><au>TIDWELL MICHAEL WADE</au><au>FILLA SANDRA ANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS</title><date>2011-11-30</date><risdate>2011</risdate><abstract>The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is -C(H) or -N ; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI2188268TT1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T13%3A23%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HELLMAN%20SARAH%20LYNNE&rft.date=2011-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2188268TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true